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Probiotics can be defined as living microbes, 
or as food ingredients containing living microbes, 
that beneficially influence the health of the host 
when used in adequate numbers.1 Both definitions 
have in common the idea that probiotic microor-
ganisms are living. Furthermore, the efficacy and 
safety of probiotics should be scientifically proven. 
Probiotic effects are strain specific; thus each in-
dividual bacterial strain must be tested separately 
for the health benefit in question, and the effects 
described for one strain cannot be directly applied 
to others.2 
Traditionally, probiotics have been associated 
with gut health, and most clinical interest has fo-
cused on the prevention or treatment of gastroin-
testinal infections and diseases; however, during 
the last decade, an increasing number of estab-
lished  and  proposed  health  effects  of  probiotic 
bacteria have been reported, including enhance-
ment of the adaptive immune response, treatment 
or prevention of urogenital and respiratory tract 
infections, and prevention or alleviation of aller-
gies and atopic diseases in infants.2,3 Several in-
vestigators have also suggested probiotics for oral 
health purposes. Interestingly, probiotics are also 
suggested to increase the lifetime of voice pros-
thesis by inhibiting the adhesion of unwanted mi-
crobes.4-6
The  most  commonly  used  probiotic  bacterial 
strains belong to the genera Lactobacillus and Bifi-
dobacterium.3 These bacterial genera are regarded 
as a part of the normal human microbiota. In the 
oral  cavity,  lactobacilli  usually  comprise  fewer 
than 1% of the total cultivable microbiota, but no 
species specific to the oral cavity has been found. 
In contrast, some species are found in both oral 
and fecal samples.7,8 Species commonly isolated 
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from saliva samples include L. paracasei, L. plan-
tarum, L. rhamnosus, and L. salivarius.7-10 Culture-
based  studies  suggest  that  bifidobacteria  are 
among the first anaerobes in the oral cavity.11 In-
deed, both lactobacilli and bifidobacteria can be 
found in breast milk, suggesting early exposure of 
the oral cavity to these bacteria.12,13 Bifidobacterial 
species isolated from oral samples include B. bifi-
dum, B. dentium, and B. longum.8,14,15
Lactobacilli  and  bifidobacteria  are  generally 
regarded as safe, and, since the early writing of 
Metchnikoff,16 even more fermented food products 
have been associated with health benefits. In re-
spect to normal microbiota and oral health, there 
seem to be differences in the ability of lactobacilli 
isolated from caries-active or healthy subjects to 
inhibit Streptococcus mutans in vitro.10 In addition, 
the species composition of both Lactobacillus and 
Bifidobacterium  microbiota  is  different  between 
patients  with  periodontitis  and  those  who  are 
periodontally healthy.17,18 On the other hand, both 
lactobacilli and bifidobacteria are also associated 
with dental caries.19,20 In addition, caries-associat-
ed lactobacilli and bifidobacteria have been char-
acterized as exogenous and opportunistic coloniz-
ers possibly acquired from food.15,21
During  the  last  few  years,  several  authors 
have suggested that probiotic bacteria originally 
planned for gut health could also be beneficial to 
oral health. The aim of this review is to examine 
potential mechanisms of probiotic bacteria in the 
oral  cavity  and  to  summarize  observed  effects 
of probiotics with respect to oral health. Finally, 
some future aspects are briefly discussed. This 
review focuses on probiotic lactobacilli and bifi-
dobacteria, genera that are most used in various 
probiotic products. 
POTENTIAL MECHANISMS OF 
PROBIOTIC EFFECTS IN THE 
ORAL CAVITY
The general mechanisms of probiotics can be 
divided into three main categories: normalization 
of  the  intestinal  microbiota,  modulation  of  the 
immune  response,  and  metabolic  effects.22  The 
mechanisms of probiotic action in the oral cavity 
could  be  analogous  to  those  described  for  the 
intestine.  Possible  ways  that  probiotics  might 
affect  oral  health  are  summarized  in  Figure  1. 
Thus  far  oral  colonization  by  probiotic  bacteria 
has  often  been  considered  essential  for  them 
to exert oral effects; however, the possibility of 
systemic  effects  cannot  be  excluded,  although 
the  total  sIgA  levels  in  saliva  seem  unaffected 
by  probiotic  use.23,24  Interestingly,  maternal  use 
of some probiotic strains seems to influence the 
composition of breast milk.25
In respect to commensal oral microbes, sever-
al aspects support the idea that it may be possible 
to  find  bacteria  that  could  be  useful  in  preven-
tion or treatment of oral diseases. In fact, it has 
been suggested that some observed probiotic ef-
fects are not just properties of a few well-studied 
strains  but  common  to  several  species.26-28  The 
ecological  plaque  hypothesis  suggests  that  se-
lective pressure in environmental conditions can 
change the balance between oral health and dis-
ease.29 As bacteria can also influence their envi-
ronment,  and  both  synergistic  and  antagonistic 
interactions are suggested for bacteria in dental 
plaque, the environmental pressure described in 
the ecological plaque hypothesis could be intro-
duced partly by bacteria. Second, it is well recog-
nized that the normal microbiota protect the oral 
cavity from infections. Finally, just as there are 
bacterial  species  associated  with  oral  diseases, 
there are also species that seem to be associated 
with oral health;20,30,31 however, it is questionable 
whether bacteria administered in food could influ-
ence relatively stable oral microbiota, in particular 
in adults. In addition, it must be kept in mind that 
all the mechanisms described in this section are 
based on in vitro results, and the clinical evidence 
is based mainly on short clinical pilot studies.
OBSERVED EFFECTS ON 
ORAL HEALTH
Caries and caries-associated microbes
Several  studies  suggest  that  consumption  of 
products  containing  probiotic  lactobacilli  or  bi-
fidobacteria could reduce the number of mutans 
streptococci in saliva.32-40 The tendency toward a 
decreased number of mutans streptococci in the 
saliva seems to be independent of the product or 
strain  used;  however,  such  effect  has  not  been 
observed  in  all  studies.41  The  discrepancies  be-
tween results cannot be explained by only the use 
of different probiotic strains, as different results 
have also been obtained using the same strains. In 
most of these studies, the levels of salivary lacto-
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Figure 1. Potential mechanisms by which probiotic bacteria could affect oral health (Modified from76, with additional references.27,28,45,46,65,74,77-79).
bacilli have also been measured. With three prod-
ucts, an increase in the number of salivary Lacto-
bacillus has been observed.33,41 Unfortunately, with 
respect to dental caries, the study groups have 
mainly been relatively small, and the studies fairly 
short. Furthermore, it is important to realize that 
the  salivary  level  of  caries-associated  microbes 
does not equate to dental caries. In fact, the mi-
crobiota of unstimulated whole saliva resembles 
that of the tongue more than of dental plaque.42 
Thus, no conclusive statement about the effects of 
probiotic bacteria on dental caries can be made.
Periodontal diseases
The  first  studies  of  the  use  of  probiotics  for 
enhancing oral health were for the treatment of 
periodontal inflammation.43 Patients with various 
periodontal diseases, gingivitis, periodontitis, and 
pregnancy gingivitis, were locally treated with a 
culture supernatant of a L. acidophilus strain. Sig-
nificant recovery was reported for almost every 
patient. There has been significant interest in us-
ing probiotics in treatment of periodontal disease 
recently, too. The probiotic strains used in these 
studies include L. reuteri strains, L. brevis (CD2), L. 
casei Shirota, L. salivarius WB21, and Bacillus subti-
lis. L. reuteri and L. brevis have improved gingival 
health,  as  measured  by  decreased  gum  bleed-
ing.44-46  The  use  of  probiotic  chewing  gum  con-
taining L. reuteri ATCC 55730 and ATCC PTA 5289 
also decreased levels of pro-inflammatory cyto-
kines in GCF,46 and the use of L. brevis decreased 
MMP (collagenase) activity and other inflamma-
tory markers in saliva.45 With L. casei Shirota and 
Bacillus subtilis no difference in test and control 
groups in gingival bleeding or measured plaque 
index was observed, but the use of L. casei Shirota 
decreased PMN elastase and MMP-3 activities in 
GCF, and gingival inflammation was lower in the 
group consuming the probiotic product, as mea-
sured by MPO activity after a four-day period of 
experimental gingivitis.47 B. subtilis seemed to re-
duce the number of periodontal pathogens.48 Use 
of tablets containing L. salivarius WB21 has been 
shown to decrease gingival pocket depth, partic-
ularly in high-risk groups such as smokers, and July 2010 - Vol.4
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also affect the number of periodontopathogens in 
plaque.49,50  Again,  although  encouraging  results 
have been observed, most studies have been fairly 
short. Furthermore, in some studies the observed 
differences were quite small, though statistically 
significant. 
Oral candida
To  the  writer’s  knowledge,  only  two  studies 
have investigated the effects of probiotic bacte-
ria on oral Candida infection in humans.33,51 When 
a test group of elderly people consumed cheese 
containing L. rhamnosus strains GG and LC705 and 
Propionibacterium  freudenreichii  ssp.  shermanii  JS 
for 16 weeks, the number of high oral yeast counts 
decreased, but no changes were observed in mu-
cosal  lesions.51  In  a  shorter  study  with  younger 
subjects, no significant difference was observed 
between effects of probiotic and those of control 
cheese on salivary Candida counts.33
Halitosis
Halitosis is not a disease but a discomfort, al-
though some oral diseases including periodontitis 
may be the underlying cause; however, in approxi-
mately 90% of cases, the origin can be found in the 
oral cavity,52 and probiotics are marketed for the 
treatment of both mouth- and gut-associated hali-
tosis. Despite that, only a few clinical studies have 
found  different  probiotic  strains  or  products  to 
be efficacious. The studied strains include E. coli 
Nisle 1917, S. salivarius K12, three Weissella confusa 
isolates, and a lactic acid–forming bacterial mix-
ture, not specified by the authors of that work.53-56 
COLONIZATION AND SAFETY OF 
PROBIOTICS IN THE ORAL CAVITY
Some probiotic Lactobacillus and Streptococcus 
strains  seem  able  to  colonize  the  oral  cavity  of 
some people during the time that products con-
taining them are in active use. However, both in 
vitro and in vivo evidence indicate that the differ-
ences  between  various  probiotic  strains,  prod-
ucts, and also host individuals are obvious.26,44,57,58 
L. rhamnosus GG and two different L. reuteri strains 
have been reported to colonize the oral cavity of 
48–100% of volunteers consuming products con-
taining  them.44,58-60  In  addition,  S.  salivarius  K12, 
used for treating oral malodor, temporarily colo-
nizes the oral cavity for a short time after use.61 
Furthermore, consumption of a mixture of seven 
different Lactobacillus strains increased the num-
ber of salivary Lactobacillus counts, although the 
identities of the strains in the saliva were not de-
termined.41 It seems feasible that probiotic bacte-
ria would colonize the oral cavity only when they 
were used in products in contact with the mouth. 
Indeed, Maukonen et al8 did not detect any of the 
probiotic bacteria administered in capsules in sa-
liva  samples.  Surprisingly,  consumption  of  cap-
sules containing a mixture of seven different Lac-
tobacillus strains increased the number of salivary 
Lactobacillus counts.41 L. reuteri ATCC 55730 (= L. 
reuteri SD2112) does not seem to influence the to-
tal number of salivary lactobacilli,36 but L. rhamno-
sus GG may increase it.33 
Maybe because long-term colonization by pro-
biotic bacteria is unlikely, albeit possible,58 poten-
tial adverse effects of probiotic bacteria in the oral 
cavity have not been a subject of much intensive 
research;  however,  probiotic  products  are  used 
widely; therefore, when dental health is consid-
ered, the acidogenicity of lactobacilli and bifido-
bacteria cannot be overlooked. For example, one 
L. salivarius strain is able to induce caries in an 
animal model,62 and another is able to make a bio-
film model more cariogenic.63
 
FUTURE ASPECTS
Recently, oral lactic acid bacteria and bifido-
bacteria  have  been  isolated  and  characterized 
for various oral health purposes, including car-
ies,  periodontal  diseases,  and  halitosis.10,56,64-68 
In addition, dairy strains have been studied with 
the aim of characterizing potential new oral pro-
biotics;69,70 thus, the new probiotic products tar-
geted for oral health purposes do not necessar-
ily comprise the same species as products now 
in  market.  Furthermore,  the  species  might  not 
necessarily belong only to genera Lactobacillus or 
Bifidobacteium. Indeed, S. salivarius K12 is used to 
treat oral malodor,55 and preliminary results have 
been published on the safety and efficacy of a pro-
biotic mouthwash containing three different oral 
streptococci for reducing the number of bacteria 
associated with dental caries and periodontitis.71
Genetically  modified  microbes  bring  a  new 
dimension  to  the  concept  of  probiotics.  One 
approach is to reduce the harmful properties of 
pathogenic  strains  naturally  colonizing  the  oral European Journal of Dentistry
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cavity.  The  modified  strain  could  then  be  used 
to replace the original pathogen. One ambitious 
and  promising  example  is  the  generation  of  an 
S. mutans strain with a complete deletion of the 
open reading frame of lactate hydrogenase and 
thus significantly reduced cariogenicity.72 Another 
option  could  be  to  enhance  the  properties  of 
a  potentially  beneficial  strain.  One  example  is 
the construction of an L. paracasei strain with a 
functional scFV (single-chain variable fragment) 
antibody binding to the surface of Porphyromonas 
gingivalis.73
Probiotics are by definition viable, and until re-
cently the viability of probiotic bacteria was usu-
ally ascertained by culture; however, both in the 
intestine and in the oral cavity, a significant pro-
portion of bacteria are not yet cultivable. In ad-
dition, bacteria in biofilms can enter a dormant 
state; therefore, it can be speculated that bacte-
ria with the ability to influence the microbiota in 
these  sites  need  not  necessarily  be  culturable. 
There has also been debate on the definition of “vi-
able,” and even whether the definition of probiotic 
should be changed. Indeed, heat-killed beneficial 
oral Streptococcus strains have been shown to ex-
ert effects similar to those of a living bacterium.74 
Furthermore,  viable  but  nonculturable  probiotic 
bacteria maintain properties of viable bacteria.75
 
SUMMARY AND CONCLUSIONS
The interest in oral probiotics has been grow-
ing  during  the  last  decades.  Most  of  the  stud-
ies  have  been  conducted  with  probiotic  strains 
originally  suggested  for  gut  health;  however,  it 
is important to realize that each of the suggested 
health benefits should be studied for each bacte-
rial strain individually. Thus, a probiotic bacterium 
in the mouth is not necessarily an oral probiotic. 
Furthermore,  it  is  quite  possible  that  the  same 
species are not optimal for all oral health purpos-
es; e.g., different properties might be desired in 
respect to dental and gingival health.
At least some of the probiotic bacteria used in 
various probiotic products may colonize the oral 
cavity during the time they are in use; thus, the ef-
fects of probiotic bacteria in the oral cavity are im-
portant to understand. Probiotic bacteria seem to 
affect both oral microbiota and immune respons-
es. On the other hand, the extent to which bacteria 
in food or in food ingredients can influence rela-
tively stable oral microbiota is difficult to predict. 
Thus, both research to unravel the mechanisms 
of possible probiotic action and long-term clinical 
trials are needed if probiotics are to provide a new 
scientifically proven means of preventing or treat-
ing oral diseases.
Several health-promoting effects of probiotic 
bacteria are well documented,2,3 and there is no 
reason to restrict the use of probiotic products be-
cause their effects on oral health are not yet well 
understood; however, their recommendation for 
dental health purposes is not yet justified.
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